A HBr molecule oscillates with a frequency of 7.91 x 1013 Hz. What is the difference in energy in eV between allowed oscillator states

An internally reversible refrigerator has a modified coefficient of performance accounting for realistic heat transfer processes of where qin is the refrigerator cooling rate, qout is the heat rejection rate, and is the power input. show that copm can be expressed in terms of the reservoir temperatures tc and th, the cold and hot thermal resistances rt,c and rt,h, and qin, as where rtot rt,c rt,h. also, show that the power input may be expressed as 1.39 a household refrigerator operates with cold- and hot-temperature reservoirs of tc 5 c and th 25 c, respectively. when new, the cold and hot side resistances are rc,n 0.05 k/w and rh,n 0.04 k/w, respectively. over time, dust accumulates on the refrigerator’s condenser coil, which is located behind the refrigerator, increasing the hot side resistance to rh,d 0.1 k/w. it is desired to have a refrigerator cooling rate of qin 750 w. using the results of problem 1.38, determine the modified coefficient of performance and the required power input w under (a) clean and (b) dusty coil conditions. internally reversible refrigerator qout qin w high-temperature reservoir low-temperature reservoir th th,i tc,i tc high-temperature side resistance low-temperature side resistance w qin th tc qinrtot tc qinrtot copm tc qinrtot th tc

Two point charges are on the y axis. a 3.90-µc charge is located at y = 1.25 cm, and a -2.4-µc charge is located at y = −1.80 cm. (a) find the total electric potential at the origin. v (b) find the total electric potential at the point whose coordinates are (1.50 cm, 0). v

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.